641 Sixth Ave, 5th Floor
New York, NY 10011
Phone: 212-524-6288 · Fax:212-524-6299
Email: [email protected] · Web: www.thecementworks.com
Founded: 2000
Officers: Partners: Susan Miller, Rico Viray; EVPs: Ed Cowen, Reid Saleeby, PeterZamiska; SVPs: Andrea Bast, Lily Chow, Ed Puydak; David Garson, SVP/creativedirector, art; Daljit Telymonde, SVP/creative director.
Financial data:
| Source | 2005 | 2004 |
| Gross Income | $8.3 mil | $5.5 mil |
| Billings | $69.5 mil | $38.3 mil |
| US Employees | 49 | 32 |
U.S. billings breakdown by media/source:
| Medium | 2005 | 2004 |
| Journals | 29.0% | 25.0% |
| Conventions/ exhibits | 5.0% | 5.0% |
| Direct marketing | 2.0% | 2.0% |
| Sales Materials | 30.0% | 31.0% |
| Consumer Media | 4.0% | 4.0% |
| Branding, strategy programs | 30.0% | 32.0% |
Healthcare accounts: UCB: Cimzia (global, U.S.); Johnson & Johnson: Tibotec (global, U.S.),TMC114, TMC-125; Pfizer/Boehringer-Ingelheim: Spiriva; Novartis Ophthalmology Portfolio:Visudyn, Genteal Portfolio, Vitalux; Bayer diabetes division: Ascensia Breeze, Ascensia Contour;Alpharma USPD Inc.: Feverall; Pfizer: advocacy program; Medco Health Solutions; EasternDental.
Accounts gained (10): Novartis ophthalmology portfolio: Visudyn, Genteal Portfolio, Vitalux;Bayer diabetes division: Ascensia Breeze, Ascensia Contour; Johnson & Johnson: TMC-114,TMC-125; UCB: global; Medco Health Solutions; Eastern Dental.
Accounts lost (1): Vicuron Pharmaceuticals, Inc.
New hires: Daljit Telymonde, SVP/creative director.
Offices: Raleigh, N.C.
